The effect of Carbamazepine on Hearing

The effect of Carbamazepine on Hearing - Carbamazepine and Hearing

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40099

Enrollment

Registered

2014-02-26

Start date

2014-09-24

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Het onderzoek heeft geen betrekking op een aandoening, maar op het normale gehoor n.a.

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18 * age * 45 - normal hearing - detectable spontaneous otoacoustic emissions in at least one ear - patients that use carbamazepine and have been advised to stop using the drug, or patients that are advised to start using the drug.

Exclusion criteria

Exclusion criteria: No detectable spontaneous otoacoustic emissions

Design outcomes

Primary

Measure	Time frame
Shift of SOAE frequencies, related to Carbamazepine usage.	—

Countries

Netherlands

Outcome results